Up to one-third of patients with status epilepticus will not respond to benzodiazepines. Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied. The longer seizures persist, the worse patients do. In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.
You can get CME credit for this episode here!Click here for CME Account Creation InstructionsMany critically ill patients are acidotic. Often, bicarbonate is administered to severely acidotic patients, but does it really improve outcomes? The BICAR-ICU was just...
The SSC recently published its new recommendations for the management of sepsis and septic shock. We discuss the key changes and controversies that you...
In recent years, the use of e-cigarette and vaping products has sharply risen. Concomitant with the increased use is an increase in patients presenting...